N. Zeghari-Squalli

Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.

E. Raymond, F. Goldwasser, E. Cvitkovic, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cellular pharmacology of the combination of oxaliplatin with topotecan in the IGROV-1 human ovarian cancer cell line.

F. Goldwasser, J. Misset, N. Zeghari-Squalli, 1999, Anti-cancer drugs.